233 related articles for article (PubMed ID: 32848801)
1. Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease
Zhao P; Liu X; Dong H; Tian Y; Feng S; Zhao D; Ren Z; Zhang L; Li J
Front Pharmacol; 2020; 11():1212. PubMed ID: 32848801
[TBL] [Abstract][Full Text] [Related]
2. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.
Zhao P; Li J; Tian Y; Mao J; Liu X; Feng S; Li J; Bian Q; Ji H; Zhang L
J Ethnopharmacol; 2018 May; 217():152-162. PubMed ID: 29454913
[TBL] [Abstract][Full Text] [Related]
3. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
[TBL] [Abstract][Full Text] [Related]
4. Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway.
Li MY; Qin YQ; Tian YG; Li KC; Oliver BG; Liu XF; Zhao P; Li JS
BMC Pulm Med; 2022 Nov; 22(1):434. PubMed ID: 36414945
[TBL] [Abstract][Full Text] [Related]
5. Effective-component compatibility of Bufei Yishen formula alleviates chronic obstructive pulmonary disease inflammation by regulating GSK3β-mediated NLRP3 inflammasome activation.
Qin Y; Zhai J; Yang J; Li H; Tian Y; Liu X; Zhao P; Li J
Biomed Pharmacother; 2023 Dec; 168():115614. PubMed ID: 37862971
[TBL] [Abstract][Full Text] [Related]
6. A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38.
Li J; Xie Y; Zhao P; Qin Y; Oliver BG; Tian Y; Li S; Wang M; Liu X
Phytomedicine; 2021 Mar; 83():153475. PubMed ID: 33545548
[TBL] [Abstract][Full Text] [Related]
7. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-
Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J
Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807
[TBL] [Abstract][Full Text] [Related]
8. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling.
Xu K; Ma J; Lu R; Shao X; Zhao Y; Cui L; Qiu Z; Tian Y; Li J
Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 36799253
[TBL] [Abstract][Full Text] [Related]
9. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease.
Li J; Zhao P; Li Y; Tian Y; Wang Y
Sci Rep; 2015 Oct; 5():15290. PubMed ID: 26469778
[TBL] [Abstract][Full Text] [Related]
10. Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model.
Li J; Yang L; Yao Q; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X; Guo Z
Evid Based Complement Alternat Med; 2014; 2014():381976. PubMed ID: 24959185
[TBL] [Abstract][Full Text] [Related]
11. Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway.
Ma J; Liu X; Wei Y; Lu R; Xu K; Tian Y; Li J
Evid Based Complement Alternat Med; 2022; 2022():9423435. PubMed ID: 36619199
[TBL] [Abstract][Full Text] [Related]
12. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
[TBL] [Abstract][Full Text] [Related]
13. Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway.
Li J; Wang J; Li Y; Zhao P; Tian Y; Liu X; He H; Jia R
Ecotoxicol Environ Saf; 2021 Nov; 228():112918. PubMed ID: 34773846
[TBL] [Abstract][Full Text] [Related]
14. [Compatibility characteristics of Bufei Yishen formula III in regulating chronic obstructive pulmonary disease mucus hypersecretion].
Qin Y; Li M; Tian Y; Zhao P; Li K; Li C; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1309-1314. PubMed ID: 34980299
[TBL] [Abstract][Full Text] [Related]
15. Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.
Jia L; Liu X; Liu X; Guan Q; Tian Y; Li J; Zhao P
Chin Med; 2024 Feb; 19(1):32. PubMed ID: 38413976
[TBL] [Abstract][Full Text] [Related]
16. Kuijieling regulates the differentiation of Treg and Th17 cells to ameliorate experimental colitis in rats.
Long Y; Li S; Qin J; Xie L; Gan L; Jie F; Wu Y; Li Y; Du Q
Biomed Pharmacother; 2018 Sep; 105():781-788. PubMed ID: 29909346
[TBL] [Abstract][Full Text] [Related]
17. Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma signaling.
Li Y; Tian YG; Li JS; Dong YQ; Wang MH; Feng SX; Li LL; Mao J; Wang LL; Luo S
J Ethnopharmacol; 2016 Dec; 193():354-361. PubMed ID: 27562320
[TBL] [Abstract][Full Text] [Related]
18. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling.
Li J; Zhao P; Yang L; Li Y; Tian Y; Li S
Sci Rep; 2016 May; 6():25492. PubMed ID: 27146975
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.
Wei Y; Liu X; Jiang Y; Guan Q; Tian Y; Li J; Zhao P
Phytomedicine; 2023 Sep; 118():154980. PubMed ID: 37499344
[TBL] [Abstract][Full Text] [Related]
20. Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease.
Li JS; Liu XF; Dong HR; Zheng WC; Feng SX; Tian YG; Zhao P; Ma JD; Ren ZX; Xie Y
J Integr Med; 2020 Jul; 18(4):351-362. PubMed ID: 32565294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
